NCT06863402 2026-03-24Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma SubtypeRoswell Park Cancer InstitutePhase 2 Recruiting32 enrolled